Thus, this finding indicated that PACS-2 may become a promising therapeutic target for atherosclerosis by regulating MAM formation and increasing levels of mitochondrial Ca2+ (Yu et al., 2019). The gene discussed is PACS2; the disease is atherosclerosis.